BIBLIOGRAFIA
1. Pelagalli G.V., Botte V. Anatomia veterinaria sistematica e comparata.
(1999). Vol 2. III Ed. Edi-ermes.
2. Bloom W., Fawcett Don W. Trattato di istologia. (1981). II Ed. Piccin- Padova.
3. Marcato P.S. Patologia sistematica veterinaria. (2002). Edagricole- Bologna.
4. Robbins e Cotran. (2004). VII Ed. Elsevier Saunders.
5. Guarda F., Mandelli G. Trattato di anatomia patologica veterinaria.
(2002). III Ed. Utet.
6. Jubb K:V.F, Kennedy P.C., Palmer N. (1992). Pathology of Domestic Animals. Vol 3. ACADEMIC PRESS, INC.
7. Russel J.C., Proctor S.D. (2006). Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovascular Pathology 15, 318-330.
8. Moghadasian M.H., DVM, MSc, PhD. (2002). Experimental atherosclerosis A historical overview. Life Sciences 70, 855-865.
9. Turk J.R., Laughlin M.H. (2004). Physical Activity and Atherosclerosis:
Which Animal Model? Can. J. Appl. Physiol. 29, 657-683.
10. Barone R. Anatomia comparata dei mammiferi domestici. (1993). Vol 5°.
Angiologia. Ed agricole.
11. Fan J., Araki M., Wu L., Challah M., Shimoyamada H., Lawn M.R., Kakuta H., Shikama H., Watanabe T. (1998a). Transgenic rabbits expressing human apolipoprotein(a). Circulation 98 (Suppl.), I-390 (Abstract).
12. Fan J., Ji Z.-S., Huang Y., de Silva H., Sanan D., Mahley R., Innerarity T., Taylor J. (1998b). Increased expression of apolipoprotein E in transgenic rabbits result in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J.
Clin. Invest. 101, 2151-2164.
13. Rouy D., Duverger N., Lin S.D., Emanuel F., Houdebine L.M., Denefle P., Viglietta C., Gong E., Rubin E.M., Hughes S.D. (1998).
Apolipoprotein(a) yeast artificial chromosome transgenic rabbits.
Lipoprotein(a) assembly with human and rabbit apolipoprotein B. J Biol Chem 273, 1247-1251.
14. Brousseau M.E., Kauffman R.D., Herderick E.E., Demosky Jr., S.J., Evans W., Marcovina S., Santamarina-Fojo S., Brewer Jr., H.B. Hoeg J.M. (2000). LCAT modulates atherogenic plasma lipoprotein and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits. Arterioscler Thromb Vasc Biol 20, 450-458.
15. Watanabe Y. (1980). Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 36, 261-268.
16. Fan J., Shimoyamada H., Sun H., Marcovina S., Honda K., Watanabe T.
(2001a). Transgenic rabbits expressing human apolipoprotein(a) develop more extensive atherosclerosis lesions in response to a cholesterol-rich diet. Arterioscler Thromb Vasc Biol 21, 88-94.
17. Sun H., Unoki H., Wang X., Liang J., Ichikawa T., Fan J. (2002).
Lipoprotein(a) enhances advanced atherosclerosis in WHHL transgenic rabbits expressing human apolipoprotein(a). J Biol Chem 277, 47486- 47492.
18. Fan J., Watanabe T. (2003). Trangenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacology & Therapeutics 99, 261-282.
19. Kitajima S., Jin Y., Koike T., Yu Y., Liu E., Shiomi M., Marcovina S.M., Morimoto M., Watanabe T., Fan J. (2006). Lp(a) enhances coronary atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits.
Atherosclerosis.
20. Fan J., Watanabe T. (2004). Lipoprotein(a) and atherosclerosis: a study from transgenic rabbits. International Congress Series 1262, 550-553.
21. Clubb Jr. F.J., Cerny J.L., Deferrari D.A., Bluter-Aucoin M.M., Willerson J.T., Buja L.M. (2001). Development of atherosclerosis plaque with endothelial distruption in Watanabe heritable hyperlipidemic rabbit aortas.
Cardiovascular Pathology 9, 1-11.
22. Hsu H.H.T., Camasho N.P., Sun F., Tawfik O., Aono H. (2000). Isolation of calcifiable vesicles from aortas of rabbits fed with high cholesterol diets. Atherosclerosis 153, 337-348.
23. Hur S.J., Du M., Nam K., Williamson M., Ahn D.U. (2005). Effect of dietary fats on blood cholesterol and lipid and the development of atherosclerosis in rabbits. Nutrition Research 25, 925-935.
24. Chiesa G., Di Mario C., Colombo N., Vignati L., Marchesi M., Monteggia E., Parolini C., Lorenzon P., Laucello M., Lo russo V., Adamian M., Franceschini G., Newton R., Sirtori C.R. (2000). Development of a lipid- rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound. Atherosclerosis 2, 277-287.
25. Wetterholm R., Caidahl K., Volkmann R., Brandt-Eliasson U., Fritsche- Danielson R., Gan L. (2006). Imaging of atherosclerosis in WHHL rabbits using high-resolution ultrasound. Ultrasound in Medicine and Biology.
(2007) Vol. 33. N° 5, pp. 720-726.
26. Ross R. (1986). The pathogenesys of atherosclerosis. An update. N. Engl.
J. Med. 314, 488-500.
27. Duverger N., Kruth H., Emanuel F., Caillaud J.M., Viglietta C., Castro G., Tailleux A., Fievet C., Fruchart J.C., Houdebine L.M., Denefle P.
(1996a). Inibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94, 713-717.
28. Lebuffe G., Boullier A., Tailleux A., Delfly B., Dupuis B., Fruchart J.C., Duverger N., Emmanuel F., Denefle P., Vallet B., Duriez P. (1997).
Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits. Biochem Biophys Res Commun 241, 205-211.
29. Huang Y., Schwendner S.W., Rall S.C., Sanan D., Mahley R.W. (1997).
Apolipoprotein E2 transgenic rabbits. J Biol Chem 272, 22865-22694.
30. Taylor M. (1997). Transgenic rabbits model for the study of atherosclerosis. Ann NY Acad Sci 811, 146-151.
31. Zimarino M., Prati F., Stabile E., Pizzicannella J., Fouad T., Filippini A., Rabozzi R., Trubiani O., Pizzicannella G., De Caterina R. (2006). Optical coherence tomography accurately identifies intermediate atherosclerotic lesions-An in vivo evaluation in the rabbit carotid artery. Atherosclerosis 1, 94-101.
32. Wang J., Geng Y.J., Guo B., Klima T. (2002). Near-infrared spectroscopic characterization of human advanced atherosclerotic plaques. Journal of the American College of Cardiology 39, 1305-1315.
33. de Korte C., Sierevogel M.J., Mastik F. (2002). Identification of atherosclerotic claque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 105, 1627-1630.
34. Casscells W., Hathorn B., M.D. (1996). Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and trombosis. Lancet 347, 1447-1449.
35. Verheye S., De Meyer GRY., Van Langenhove G. (2002). In vivo temperature heterogeneity of atherosclerotic plaque is determined by plaque composition. Circulation 105, 1596-1601.
36. Siegel R.J., Ariani M., Fishbein MC. (1991). Histopathologic validation of angioscopy and intravascular ultrasound. Circulation 84, 109-117.
37. Nissen S.E., Gurley J.C., Grines C.L. (1991). Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 84, 1087-1099.
38. Prati F., Arbustini E., Labbellarte A., Boccanelli A. (2001). Correlation between high frequency intravascular ultrasound and histomorphology in human coronary arteries. Heart 85, 567-570.
39. Michev I., Margolis P., Vitrella G., Iakovou I., Vince D.G., Colombo A., Airoldi F., Gaddis M.L., Chieffo A. Virtualy histology reconstruction of intravascular ultrasound imaging: in vivo correlation with histology on samples obtained from directional atherectomy. The American Journal of Cardiology. September 30, 2004. TCT ABSTRACTS 247-252.
40. Kuchulakanti P., Woon Rha S., Cheneau E., Satler L., Pichard A., Kent K., Waksman R. (2003). Identification of “vulnerable plaque” using virtual histology in angiographically benign looking lesion of proximal left anterior descending artery. Cardiovascular Radiation Medicine 4, 225-227.
41. Fujii K., G. Carlier S., Mints G.S., Wjins W., Colombo A., Bose D., Erbel R., de Ribamar Costa J., Kimura M., Sano K., Costa R.A., Lui J., Stone G.W., Moses J.W., Leon M.B. (2005). Association of plaque charaterization by intravascular ultrasound virtual histology and arterial remodeling. The American Journal of Cardiology 11, 1476-1483.
42. Stary H.C., Chandler A.B., Dinsmore R.E. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the council on atherosclerosis, American Heart Association. Circulation 92, 1355-1374.
43. Yucel E.K., Anderson C.M., Edelman R.R., Grist T.M., Baum R.A., Manning W.J., Culebras A., Prearce W. (1999). Magnetic resonance angiography: update on applications for extracranial arteries. Circulation 100, 2284-2310.
44. Regenfus M., Ropers D., Achenbach S., Kessler W., Laub G., Daniel W.G., Moshage W. (2000). Noninvasive detection of coronary artery stenosis using contrast-enhanced three-dimensional breath-hold magnetic resonance coronary angiography. Journal of the American College of Cardiology 36, 44-50.
45. Wang Y-X. J., Kuribayashi H., Wågberg M., Holmes A.P., Tessier J.J., Waterton J.C. (2006). Gradient echo MRI characterization of development of atherosclerosis in the abdominal aorta in Watanabe
Heritable Hyperlipidemic Rabbits. CardioVascular and Interventional Radiology.
46. Helft G., Worthley S.G., Fuster V., Zaman A.G., Schechter C., Osende J.I., Rodriguez O.J., Fayad Z.A., Fallon J.T., Badimon J.J. (2000).
Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. Journal of the American College of Cardiology 4, 735-1097.
47. McConnell M.V., Aikawa M., Maier S.E., Ganz P., Libby P., Lee R.T.
(1999). MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. Arteriosclerosis, Thrombosis, and Vascular Biology 19, 1956- 1959.
48. Hegyi L., Hockings P.D., Benson M.G., Busza A.L., Overend P., Grimsditch D.C., Burton K.J., Lioyd H., Whelan G.A., Skepper J.N., Vidgeon-Hart M.P., Carpenter A.T., Reid D.G., Suckling K.E., Weissberg P.L. (2004). Short term arterial remodelling in the aortae of cholesterol fed New Zealand white rabbits shown in vivo by high-resolution magnetic resonance imaging – implication for human pathology. Pathol. Oncol.
Res.
49. Skinner M.P., Yuan C., Mitsumori L., Hayes C.E., Raines E.W., Nelson J.A., Ross R. (1995). Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complication in vivo. Nat. Med. 1, 69-73.
50. Chiesa G., Rigamonti E., Monteggia E., Parolini C., Marchesi M., Miragoli L., Grotti A., Maggioni F., Lorusso V., Sirtori C.R. (2004).
Evaluation of a soft atherosclerotic lesion in the rabbit aorta by an invasive IVUS method versus a non-invasive MRI technology.
Atherosclerosis 174, 25-33.
SITOGRAFIA
51. Aterosclerosi – Wikipedia. http://www.wikipedia.it.
52. Il rischio cardiovascolare nella donna. http:// www.cardiometabolica.org.
53. Dr. Boncompagni E. Il colesterolo. http:// www.cardiologiapertutti.org.
54. Dr. La Rosa A. I fattori di rischio dell’aterosclerosi. http://
www.farmasalute.it.
55. Il colesterolo e i grassi. http:// www.dietaweb.it.
56. Caparrotta L. L’invecchiamento del coniglio Watanabe geneticamente iperlipidemico: correlazione tra paramentri biochimici e funzionali nel tessuto vasale aortico e fattori di rischio a livello ematico.
http://www.angin.cnr.it.
57. Prati F., Manzoli A., Imola F. La placca vulnerabile.
http://www.emodinamica.gise.it.
58. Angiografia. http://www.paginemediche.it.
59. Valutazione non invasiva di lesioni ateromasiche sperimentali e dell’efficacia di trattamenti biologici. Università degli Studi di Milano.
http://www.ricercaitaliana.it.
60. http:// www.med.kobe-u.ac.jp/iea/w-index.html.
61. Imaging a risonanza magnetica-Wikipedia. http://www.wikipedia.it.
62. Pingitore A., Lombardi M., Morelos M. Coronarografia e risonanza magnetica: un approccio integrato e non invasivo per lo studio della placca aterosclerotica coronarica. http://www.emodinamica.gise.it.
63. Ratti C., Chiurlia E., Menozzi M., Barbieri A., Modena M.G. (2005). Il calcio coronarico come marker precoce di aterosclerosi. Annali Italiani Medicina Interna. Vol 20. N 3. http://www.simi.it.
64. Tomografia computerizzata – Wikipedia. http://www.wikipedia.it.
